Setting care priorities for older women after breast cancer treatment
Patient Priorities for Survivorship Care in Older Breast Cancer Survivors
This project will test a patient‑priorities approach to see if it helps older women who finished breast cancer treatment get survivorship care that matches their goals.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 65 Years to 100 Years |
| Sex | Female |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 3 sites (Bellaire, Texas and 2 other locations) |
| Trial ID | NCT06478589 on ClinicalTrials.gov |
What this trial studies
Researchers will adapt the Patient Priorities Care (PPC) framework to the breast cancer survivorship setting using a user-centered, iterative process with input from patients, oncologists, geriatricians, and patient advocates. The adapted intervention consists of a facilitator-led health priorities identification session followed by an oncology visit to align the care plan with those priorities. After refinement by an advisory panel, participants will be randomized to the adapted PPC versus usual care in a randomized quality improvement project. Primary outcomes include feasibility, treatment burden and quality of life at 3 months, and adherence to priorities-driven survivorship recommendations at 12 months.
Who should consider this trial
Good fit: Ideal candidates are English-speaking older women with stage DCIS–III breast cancer who are 3 months to 10 years post‑treatment and have multiple chronic conditions, high medication use, recent hospitalizations or ED visits, or multiple specialty visits.
Not a fit: Patients currently receiving active cancer therapy, non-English speakers, survivors less than 3 months or more than 10 years from treatment, or those without multiple comorbidities are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, the approach could help older survivors receive more personalized survivorship care, reduce treatment burden, and improve quality of life.
How similar studies have performed: PPC-style approaches have shown feasibility and promise in older adults with multimorbidity, but adapting this framework specifically for breast cancer survivorship is a novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * able to write and speak English * Stage DCIS/I/II/III breast cancer diagnosis * 3 months from active cancer therapy (including first or second-line treatment chemotherapy, radiation and/or surgery, or multimodal treatment) up to 10 years since completing treatment * ≥3 documented comorbidities by chart review, or taking ≥10 medications, have ≥ 1 hospitalization over the past year, ≥ 2 emergency department visits over the past year, seen by \> 2 specialists over the past year * able to provide consent Exclusion Criteria: * currently on active cancer therapy (including first or second-line treatment chemotherapy, radiation and/or surgery, or multimodal treatment)
Where this trial is running
Bellaire, Texas and 2 other locations
- UT Physicians Center for Healthy Aging Bellaire — Bellaire, Texas, United States (Recruiting)
- UT Physicians Family Medicine Bayshore — Houston, Texas, United States (Recruiting)
- Memorial Hermann Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Dana E. Giza, MD — The University of Texas Health Science Center, Houston
- Study coordinator: Dana E. Giza, MD
- Email: Dana.E.Giza@uth.tmc.edu
- Phone: (713) 500-6087
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.